CMPX vs MNST · $367.4M cap vs P/E 46, rev $8.29B
Compass Therapeutics Inc. (CMPX) versus Monster Beverage Corp (MNST) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
Monster Beverage Corp (MNST) is a beverages - non-alcoholic company listed on US.
CMPX does not have a complete income-statement cache yet.
Latest reported MNST revenue for 2025-12-31 was $8.29B. Net income was $1.91B. Revenue was up 10.7% from 2024-12-31 to 2025-12-31. MNST currently screens at market cap $94.01B and trailing P/E 46.4.
CMPX currently screens at market cap $367.4M. MNST currently screens at market cap $94.01B and trailing P/E 46.4.
Not investment advice. Open the CMPX and MNST stock pages for the full models.
Not investment advice.